Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Wuxi Apptec 2359.HK | Pharmaceuticals: Major | $66.3B | -11% | +40% | +38% | 44% | 20.4× |
| Jiangsu Hengrui Pharmaceuticals 1276.HK | Pharmaceuticals: Major | $48.8B | +6% | -20% | +11% | 27% | 32.1× |
| Hansoh Pharma 3692.HK | Pharmaceuticals: Major | $26.9B | +3% | -7% | +25% | 38% | 27.5× |
| Wuxi Bio 2269.HK | Biotechnology | $25.0B | -16% | +43% | +22% | 32% | 28.7× |
| Innovent Biologics 1801.HK | Pharmaceuticals: Major | $19.2B | -11% | -5% | +43% | 17% | 53.3× |
| Jd Health 6618.HK | Drugstore Chains | $17.6B | +22% | -7% | +26% | 6% | 19.4× |
| Sichuan Kelun-Biotech Biopharmaceutical 6990.HK | Pharmaceuticals: Major | $13.9B | -3% | 0% | +44% | -38% | 1,255.9× |
| Sbp 1177.HK | Pharmaceuticals: Major | $12.7B | -1% | +4% | +15% | 30% | 18.3× |
| Cspc Pharma 1093.HK | Biotechnology | $12.4B | -14% | +5% | +25% | 28% | 9.3× |
| WuXi XDC Cayman 2268.HK | Miscellaneous Commercial Services | $11.4B | -16% | +23% | +42% | 28% | 39.5× |
| Pharmaron Beijing 3759.HK | Pharmaceuticals: Major | $11.3B | -9% | +45% | +24% | 14% | 22.9× |
| Akeso 9926.HK | Pharmaceuticals: Major | $10.2B | -22% | -38% | +42% | -25% | n/a |
| Genscript Biotech 1548.HK | Biotechnology | $8.81B | -29% | +96% | +53% | 12% | 297.9× |
| Shanghai Fosun Pharmaceutical (Group) 2196.HK | Pharmaceuticals: Major | $8.69B | -5% | -10% | +10% | 6% | 10.4× |
| Shanghai Pharmaceuticals 2607.HK | Pharmaceuticals: Major | $8.48B | +5% | -7% | +9% | 3% | 6.6× |
| Asymchem Laboratories (Tianjin) 6821.HK | Pharmaceuticals: Major | $8.19B | -22% | +22% | +24% | 17% | 29.2× |
| RemeGen 9995.HK | Pharmaceuticals: Major | $6.92B | -2% | -31% | +293% | 61% | 7.4× |
| Sinopharm 1099.HK | Medical Distributors | $6.83B | +16% | -4% | +3% | 3% | 6.3× |
| Ali Health 0241.HK | Information Technology Services | $6.39B | +10% | -33% | +14% | 5% | 20.9× |
| Hangzhou Tigermed Consulting 3347.HK | Biotechnology | $5.65B | -14% | -1% | +22% | 10% | 71.8× |
| 3SBio 1530.HK | Biotechnology | $4.92B | -3% | -34% | +102% | 61% | 13.7× |
| Guangzhou Baiyunshan Pharmaceutical 0874.HK | Pharmaceuticals: Major | $4.56B | 0% | -23% | +6% | 3% | 7.3× |
| JOINN Laboratories (China) 6127.HK | Biotechnology | $4.43B | -19% | +9% | +17% | -4% | 18.6× |
| Shanghai Junshi Biosciences 1877.HK | Pharmaceuticals: Major | $4.08B | -12% | -39% | +36% | -14% | n/a |
| China Resources Pharmaceutical 3320.HK | Pharmaceuticals: Major | $3.74B | +9% | -11% | +8% | 4% | 6.0× |
| Livzon Pharmaceutical 1513.HK | Pharmaceuticals: Major | $3.69B | +13% | -11% | -10% | 19% | 11.3× |
| Simcere Pharmaceutical 2096.HK | Pharmaceuticals: Major | $3.63B | -3% | -7% | +27% | 18% | 14.3× |
| Shanghai Henlius Biotech 2696.HK | Pharmaceuticals: Major | $3.41B | -14% | -37% | +33% | 12% | 23.8× |
| XtalPi 2228.HK | Biotechnology | $3.35B | -16% | -34% | +4% | -127% | n/a |
| China Medical System 0867.HK | Pharmaceuticals: Major | $3.30B | 0% | -16% | +15% | 20% | 10.9× |
| Fameglow 3774.HK | Medical/Nursing Services | $3.19B | +10% | n/a | +36% | 11% | n/a |
| Zai Lab 9688.HK | Biotechnology | $2.92B | -8% | +13% | +5% | -59% | n/a |
| Sunshine Lake Pharma 6887.HK | Biotechnology | $2.85B | -6% | -9% | +20% | -3% | n/a |
| InSilico Medicine Cayman TopCo 3696.HK | Pharmaceuticals: Major | $2.80B | -29% | -43% | +153% | -7% | 100.0× |
| HUTCHMED (China) 0013.HK | Pharmaceuticals: Major | $2.58B | +4% | +9% | -9% | -6% | 40.8× |
| Keymed Biosciences 2162.HK | Pharmaceuticals: Major | $2.48B | -11% | -6% | 0% | -73% | 18.6× |
| InnoCare Pharma 9969.HK | Pharmaceuticals: Major | $2.31B | -10% | -13% | +146% | 35% | 37.0× |
| Shanghai Conant Optical 2276.HK | Medical Specialties | $2.27B | -7% | -27% | +8% | 29% | 22.1× |
| Health and Happiness (H&H) International 1112.HK | Pharmaceuticals: Other | $2.05B | +29% | +70% | +24% | 16% | 12.6× |
| Grand Pharmaceutical 0512.HK | Pharmaceuticals: Major | $2.01B | -8% | -27% | +7% | 13% | 9.8× |
| United Laboratories International 3933.HK | Pharmaceuticals: Major | $2.00B | +5% | -19% | -13% | 5% | 14.5× |
| Shandong Weigao Group Medical Polymer 1066.HK | Medical Specialties | $1.96B | +5% | -4% | +7% | 14% | 8.8× |
| Shenzhen Hepalink Pharmaceutical 9989.HK | Pharmaceuticals: Major | $1.89B | +6% | -18% | -1% | 8% | 8.3× |
| Angelalign Technology 6699.HK | Medical Specialties | $1.74B | -5% | -7% | +84% | 9% | 52.1× |
| CanSino Biologics 6185.HK | Biotechnology | $1.71B | -30% | -5% | +36% | -4% | 74.9× |
| Consun Pharmaceutical 1681.HK | Pharmaceuticals: Major | $1.65B | +6% | +5% | +15% | 35% | 9.2× |
| Ping An Healthcare and Technology 1833.HK | Medical/Nursing Services | $1.63B | -2% | -47% | +8% | 3% | 40.1× |
| Fujian Haixi Pharmaceuticals 2637.HK | Biotechnology | $1.53B | -2% | -41% | +25% | 33% | 48.2× |
| Vigonvita Life Sciences 2630.HK | Pharmaceuticals: Generic | $1.48B | -16% | -11% | +763% | -327% | n/a |
| Ascentage Pharma Group International 6855.HK | Pharmaceuticals: Major | $1.39B | +1% | -33% | +70% | -220% | n/a |
| Mabwell (Shanghai) Bioscience 2493.HK | Pharmaceuticals: Major | $1.37B | -13% | -32% | +21% | -127% | n/a |
| Shenzhen Edge Medical 2675.HK | Medical Specialties | $1.31B | -21% | -51% | +132% | 2% | 130.1× |
| Duality Biotherapeutics 9606.HK | Biotechnology | $1.23B | -47% | -60% | -5% | -181% | n/a |
| Everest Medicines 1952.HK | Pharmaceuticals: Major | $1.22B | -6% | -20% | +193% | -5% | 26.9× |
| HBM 2142.HK | Pharmaceuticals: Other | $1.18B | -19% | -23% | +55% | 44% | 12.4× |
| Shandong Xinhua Pharmaceutical 0719.HK | Pharmaceuticals: Other | $1.09B | -6% | -11% | -1% | 4% | 6.8× |
| CStone Pharmaceuticals 2616.HK | Pharmaceuticals: Major | $1.07B | -8% | -38% | +117% | -89% | n/a |
| Genfleet Therapeutics (Shanghai) 2595.HK | Pharmaceuticals: Major | $1.07B | -32% | -47% | -55% | -457% | n/a |
| SSY 2005.HK | Pharmaceuticals: Major | $990M | -4% | +10% | -4% | 12% | 13.0× |
| Sihuan Pharmaceutical 0460.HK | Pharmaceuticals: Other | $952M | +12% | -35% | +30% | 15% | 9.7× |
| Suzhou Ribo Life Science 6938.HK | Pharmaceuticals: Generic | $939M | -19% | -29% | +4% | -187% | n/a |
| Nanjing Leads Biolabs 9887.HK | Biotechnology | $927M | -26% | -54% | n/a | -108% | n/a |
| Shanghai Haohai Biological Technology 6826.HK | Medical Distributors | $926M | +3% | -27% | -5% | -2% | 7.9× |
| LifeTech Scientific 1302.HK | Medical Specialties | $914M | +27% | -18% | +1% | 12% | 23.5× |
| Modern Dental 3600.HK | Medical Specialties | $871M | -7% | +19% | +12% | 22% | 8.8× |
| Hygeia Healthcare 6078.HK | Pharmaceuticals: Major | $861M | +17% | -7% | +2% | 14% | 11.0× |
| Zylox-Tonbridge Medical Technology 2190.HK | Medical Specialties | $851M | -10% | -13% | +39% | 25% | 15.9× |
| Luye Pharma 2186.HK | Pharmaceuticals: Major | $839M | -6% | -36% | +3% | 18% | 8.1× |
| CARsgen Therapeutics 2171.HK | Pharmaceuticals: Major | $825M | -12% | -54% | +68% | -170% | n/a |
| Jinxin Fertility 1951.HK | Medical/Nursing Services | $800M | +2% | -2% | +7% | 11% | 24.4× |
| Cofoe Medical Technology 1187.HK | Medical Specialties | $798M | -1% | -27% | +40% | 10% | 12.5× |
| Shanghai INT Medical Instruments 1501.HK | Medical Specialties | $784M | -12% | -25% | +35% | 21% | 17.8× |
| Alphamab Oncology 9966.HK | Biotechnology | $777M | -23% | -39% | -32% | -38% | n/a |
| Shaanxi Micot Pharmaceutical Technology 2335.HK | Biotechnology | $777M | -14% | n/a | n/a | n/a | n/a |
| China Traditional Chinese Medicine 0570.HK | Pharmaceuticals: Major | $771M | 0% | -29% | -16% | 0% | n/a |
| China Shineway Pharmaceutical 2877.HK | Pharmaceuticals: Other | $719M | +1% | -21% | -18% | 25% | 7.2× |
| Beijing Chunlizhengda Medical Instruments 1858.HK | Medical Specialties | $671M | +6% | -27% | -9% | 31% | 9.2× |
| AK Medical 1789.HK | Medical Specialties | $664M | -1% | -26% | +16% | 26% | 10.8× |
| Lepu Biopharma 2157.HK | Pharmaceuticals: Major | $663M | -26% | -45% | +47% | 7% | 61.2× |
| CK Life Sciences International (Holdings) 0775.HK | Pharmaceuticals: Other | $644M | -1% | -30% | 0% | 0% | n/a |
| Beijing Tong Ren Tang Chinese Medicine 3613.HK | Pharmaceuticals: Major | $617M | +6% | -22% | -21% | 32% | 10.9× |
| Ascletis Pharma 1672.HK | Biotechnology | $610M | -46% | -73% | -59% | -71,976% | n/a |
| Abbisko Cayman 2256.HK | Pharmaceuticals: Major | $589M | -27% | -48% | -83% | -520% | n/a |
| Alebund Pharmaceuticals (Jiangsu) 9637.HK | Biotechnology | $576M | -33% | n/a | +674% | -495% | n/a |
| LongBio Pharma (Suzhou) 1779.HK | Biotechnology | $554M | -42% | n/a | n/a | n/a | n/a |
| Tong Ren Tang Technologies 1666.HK | Pharmaceuticals: Major | $484M | -4% | -23% | -14% | 12% | 7.2× |
| China Isotope & Radiation 1763.HK | Medical Specialties | $478M | -10% | -38% | -5% | 13% | 6.7× |
| Hanx Biopharmaceuticals (Wuhan) 3378.HK | Biotechnology | $469M | -2% | -13% | n/a | n/a | n/a |
| Jacobio Pharmaceuticals 1167.HK | Biotechnology | $468M | -24% | -27% | +286% | 68% | 6.3× |
| Jenscare Scientific 9877.HK | Medical Specialties | $463M | -14% | -32% | +993% | -106% | n/a |
| Bayzed Health 2609.HK | Hospital/Nursing Management | $453M | -9% | -49% | -2% | 5% | n/a |
| TenNor Therapeutics Suzhou 6872.HK | Biotechnology | $440M | -42% | n/a | n/a | n/a | n/a |
| Qyuns Therapeutics 2509.HK | Biotechnology | $415M | -18% | -17% | +230% | 56% | 10.0× |
| China Resources Medical 1515.HK | Hospital/Nursing Management | $415M | +10% | -12% | 0% | 6% | 5.7× |
| Medcaptain Medical Technology 2041.HK | Medical Specialties | $412M | -15% | n/a | +19% | 3% | n/a |
| ADICON 9860.HK | Medical/Nursing Services | $408M | -8% | +9% | +1% | 4% | 25.5× |
| Edding Genor 6998.HK | Biotechnology | $408M | -4% | -45% | +1,418% | 26% | n/a |
| Beijing Luzhu Biotechnology 2480.HK | Biotechnology | $390M | -4% | -33% | n/a | n/a | 26.1× |
| OrbusNeich Medical 6929.HK | Medical Specialties | $389M | -1% | -3% | +16% | 23% | 8.3× |
| Star Sports Medicine 1609.HK | Medical Specialties | $367M | -31% | -76% | +23% | 37% | n/a |
| Zhejiang Laifual Drive 3952.HK | Biotechnology | $363M | -37% | n/a | +142% | -11% | n/a |
| Medtide 3880.HK | Biotechnology | $358M | -5% | -9% | +14% | 36% | 11.4× |
| Viva Biotech 1873.HK | Biotechnology | $354M | -21% | -14% | +7% | 10% | 9.5× |
| BioDlink International 1875.HK | Pharmaceuticals: Major | $342M | -6% | -29% | -51% | -31% | 295.1× |
| Peijia Medical 9996.HK | Medical Specialties | $340M | -19% | -34% | +21% | -13% | 335.5× |
| Laekna 2105.HK | Biotechnology | $328M | -24% | -57% | n/a | -57% | n/a |
| IMPACT Therapeutics 7630.HK | Biotechnology | $325M | -38% | n/a | +395% | -173% | n/a |
| TransThera Sciences (Nanjing) 2617.HK | Biotechnology | $323M | -20% | -83% | n/a | -751% | n/a |
| Shanghai Pioneer 1345.HK | Medical Distributors | $300M | -9% | -18% | -6% | 11% | n/a |
| HJ Science 6132.HK | Biotechnology | $300M | -17% | n/a | +621% | -967% | n/a |